Replies to post #14085 on Generex Biotechnology Corp. (fka GNBTQ)

[docj]

Go to slide 10. You will find we are already 6 months behind schedule using the IND submittal as a reference. My best guess is 8 weeks after IND is submitted the trial could begin. Assuming the FDA approves without requesting more work to be done first.

https://s3.amazonaws.com/cdn.irdirect.net/PIR/1396/4932/NGIO.Presentation.9%2027%2020%20V3.pdf